386 related articles for article (PubMed ID: 9074807)
1. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism.
Felicia ND; Rekha GK; Murphy SE
Arch Biochem Biophys; 2000 Dec; 384(2):418-24. PubMed ID: 11368333
[TBL] [Abstract][Full Text] [Related]
3. Heterologous expression of CYP2K1 and identification of the expressed protein (BV-CYP2K1) as lauric acid (omega-1)-hydroxylase and aflatoxin B1 exo-epoxidase.
Yang YH; Miranda CL; Henderson MC; Wang-Buhler JL; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1279-83. PubMed ID: 11038153
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe.
Wang H; Dick R; Yin H; Licad-Coles E; Kroetz DL; Szklarz G; Harlow G; Halpert JR; Correia MA
Biochemistry; 1998 Sep; 37(36):12536-45. PubMed ID: 9730826
[TBL] [Abstract][Full Text] [Related]
5. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
Liu C; Zhuo X; Gonzalez FJ; Ding X
Mol Pharmacol; 1996 Oct; 50(4):781-8. PubMed ID: 8863822
[TBL] [Abstract][Full Text] [Related]
6. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11.
Putt DA; Ding X; Coon MJ; Hollenberg PF
Carcinogenesis; 1995 Jun; 16(6):1411-7. PubMed ID: 7788862
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5.
Jalas JR; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362
[TBL] [Abstract][Full Text] [Related]
9. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells.
Pelkonen P; Lang MA; Wild CP; Negishi M; Juvonen RO
Eur J Pharmacol; 1994 Nov; 292(1):67-73. PubMed ID: 7867691
[TBL] [Abstract][Full Text] [Related]
10. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
[TBL] [Abstract][Full Text] [Related]
11. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.
Kinonen T; Pasanen M; Gynther J; Poso A; Järvinen T; Alhava E; Juvonen RO
Br J Pharmacol; 1995 Nov; 116(6):2625-30. PubMed ID: 8590980
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
14. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
15. The roles of individual amino acids in altering substrate specificity of the P450 2a4/2a5 enzymes.
Negishi M; Uno T; Honkakoski P; Sueyoshi T; Darden TA; Pedersen LP
Biochimie; 1996; 78(8-9):685-94. PubMed ID: 9010596
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal size-effect relationship of the key residues in determining regio- and stereospecificities of DHEA hydroxylase activity in P450 2a5.
Uno T; Mitchell E; Aida K; Lambert MH; Darden TA; Pedersen LG; Negishi M
Biochemistry; 1997 Mar; 36(11):3193-8. PubMed ID: 9115996
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
Ueng YF; Shimada T; Yamazaki H; Guengerich FP
Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes.
Kim BR; Oh HS; Kim DH
Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444
[TBL] [Abstract][Full Text] [Related]
20. Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract.
He XY; Tang L; Wang SL; Cai QS; Wang JS; Hong JY
Int J Cancer; 2006 Jun; 118(11):2665-71. PubMed ID: 16385575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
